trending Market Intelligence /marketintelligence/en/news-insights/trending/S5KlhYwjWFUdWHFf9AxwAQ2 content esgSubNav
In This List

CorMedix appoints director

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


CorMedix appoints director

CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.

Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.